| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| gallopamil | sarcoplasmic/endoplasmic reticulum calcium atpase 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Asthma[MeSHID:D001249] |
7.07 | phase 2 | unknown |
| gallopamil | neutral endopeptidase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Asthma[MeSHID:D001249] |
1.63 | phase 2 | unknown |
| gallopamil | angiotensin-converting enzyme | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Asthma[MeSHID:D001249] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||